US Stocks
/
Imunon, Inc. Share Price

Imunon, Inc. Share Price

NASDAQ: IMNN | Micro Cap
$1.60
+0.00 (0.00%) Last updated on 12 Aug, 2026 | 21:47 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Imunon, Inc. Stock Performance

Open
$1.60
Prev. Close
$1.60
Circuit Range
N/A
Day Range
$1.60 - $1.60
Year Range
$1.48 - $7.09
Volume
372
Average Traded
$1.60

Imunon, Inc. Share Price Today

As of 13 August 2026, Imunon, Inc.'s share price is $1.60. The stock opened at $1.60, compared to its previous close of $1.60. During today's trading session, Imunon, Inc.'s share price traded between $1.60 and $1.60, with an average price of $1.60. Over the past 52 weeks, the stock has recorded a high of $7.09 and a low of $1.48. In terms of performance, Imunon, Inc.'s share price has declined by 49.21% over the last six months and is down 73.90% on a year-on-year basis.

Imunon, Inc. Share Price Chart

$1.60$1.60
L
Show Current Price
H

Imunon, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.40M
PE Ratio (TTM)
-0.23
Dividend Yield
N/A
EPS (TTM)
$-6.83
Revenue (TTM)
$500000.00
Return On Equity (TTM)
-205.26%
Profit Margin
-2899.01%
Debt to Equity
0.65
Quarterly Earnings Growth YoY
29.23%

Imunon, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$4.93M-$4.79M-$4.85M-$4.10M-$2.74M-$3.43M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A2.87%-1.20%15.33%33.20%-25.12%

Imunon, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022
Revenue$500000.00$500000.00
Net Profit-$20.77M-$35.90M
Net Profit Margin-4153.85%-7179.65%
Income ChangeN/A-72.84%

About Imunon, Inc.

Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; and PlaCCine for the coding of viral antigens that can elicit a strong immunological response. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.

Imunon, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$1.57
$1.60
+0.63%
Jul 2026
$1.83
$1.59
-13.11%
Jun 2026
$2.25
$1.83
-16.06%
May 2026
$2.75
$2.18
-21.86%
Apr 2026
$2.90
$2.79
-3.79%
Mar 2026
$3.29
$2.90
-7.94%
Feb 2026
$3.25
$3.15
-5.26%
Jan 2026
$3.96
$3.33
-7.12%
Dec 2025
$4.04
$3.58
-11.80%
Nov 2025
$4.57
$4.06
-10.99%
Oct 2025
$5.22
$4.56
-12.31%
Sep 2025
$5.85
$5.20
-15.17%

IMNN Share Price FAQs

What is Imunon, Inc. share price today?

chevron-up
Imunon, Inc. share price today is $1.60 as on August 12, 2026 at 9:47 pm IST.

What is the 52 week high and 52 week low of Imunon, Inc. stock?

chevron-up
The 52 week high of Imunon, Inc. stock is $7.09, while the 52 week low is $1.48 as of 12 Aug '26.

What is IMNN's market capitalisation today?

chevron-up
IMNN market capitalisation is $3.40M as of August 13, 2026, at 11:23 am IST.

What is IMNN's net income for the last quarter?

chevron-up
IMNN's net income for the last quarter is -0.00B USD.

What is the 5 year returns of IMNN?

chevron-up
The 5 year returns of IMNN is -89.94% as on 12 Aug '26.

What is the high & low stock price of IMNN today?

chevron-up
IMNN stock price hit a high of $1.60 and low of $1.60 as of 12 Aug '26.

Can I buy IMNN shares in India?

chevron-up
Yes. You can buy IMNN in India by opening an international trading account.